Article Information
PubMed
Print ISSN
Online ISSN
History
- Published online June 16, 2021.
Article Versions
- You are currently viewing an Earlier version of this article (June 16, 2021 - 09:52).
- View the most recent version of this article
Copyright & Usage
Copyright © 2020 American Society for Pharmacology and Experimental Therapeutics
Author Information
- Matilde Lopez-Grancha1,
- Patrick Bernardelli2,
- Nicolas Moindrot1,
- Elisabeth Genet1,
- Carine Vincent1,
- Valerie Roudieres1,
- Alain Krick3,
- Jean-Francois Sabuco4,
- David Machnik5,
- Delphine Ibghi1,
- Laurent Pradier1, and
- Veronique Taupin6,*
- 1Neurodegeneration Cluster, Rare and Neurologic Disease Research TA, Sanofi R&D, France
- 2Integrated Drug Discovery, Sanofi R&D, France
- 3DMPK, Sanofi R&D, France
- 4medicinal chemistry, evotec Id, France
- 5Integrated drug discovery, Sanofi R&D, France
- 6PreClinicalSafety, Sanofi R&D, France
- ↵* Corresponding Author:
Veronique Taupin, PreClinicalSafety, Sanofi R&D, 371 Av Prof. Blayac, Montpellier, N/A, 34184, France. E-mail: veronique.taupin{at}sanofi.com